Global Forskolin Market Growth 2023-2029
Forskolin is extracted from the roots of the Indian coleus (Coleus forskohlii), a tropical plant related to the mint family. Forskolin compound is a diterpene that plays a major role in the reduction of inflammation.
LPI (LP Information)' newest research report, the “Forskolin Industry Forecast” looks at past sales and reviews total world Forskolin sales in 2022, providing a comprehensive analysis by region and market sector of projected Forskolin sales for 2023 through 2029. With Forskolin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Forskolin industry.
This Insight Report provides a comprehensive analysis of the global Forskolin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Forskolin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Forskolin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Forskolin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Forskolin.
The global Forskolin market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Forskolin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Forskolin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Forskolin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Forskolin players cover Sabinsa Corporation, Bioprex Labs, Nutra Green Biotechnology, Varion Lifesciences, Glentham Life Sciences and Manus Aktteva Biopharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Forskolin market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Low Purity(Below 97%)
Purity(Above 97% and Below 99%)
High Purity(Above 99%)
Others
Segmentation by application
Weight Management
Respiratory Disorders
Digestive Disorders
Insomnia
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sabinsa Corporation
Bioprex Labs
Nutra Green Biotechnology
Varion Lifesciences
Glentham Life Sciences
Manus Aktteva Biopharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Forskolin market?
What factors are driving Forskolin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Forskolin market opportunities vary by end market size?
How does Forskolin break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Please note: The report will take approximately 2 business days to prepare and deliver.